PCN105 Comparison of Healthcare Costs in France of Combination Nivolumab and Ipilimumab Treatment Versus Nivolumab Monotherapy and Ipilimumab Monotherapy in Advanced Melanoma
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.242
https://www.valueinhealthjournal.com/article/S1098-3015(20)32498-0/fulltext
Title :
PCN105 Comparison of Healthcare Costs in France of Combination Nivolumab and Ipilimumab Treatment Versus Nivolumab Monotherapy and Ipilimumab Monotherapy in Advanced Melanoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32498-0&doi=10.1016/j.jval.2020.08.242
First page :
Section Title :
Open access? :
No
Section Order :
10190